Xiongtao Yang1, Qing Yang1, Yuan Tang1, Jing Ma2, Huamei Ye3. 1. Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610041, People's Republic of China. 2. Business School, Sichuan University, Chengdu, 610064, People's Republic of China. 3. People's Hospital of Dujiangyan City, Chengdu, 611830, People's Republic of China.
Abstract
PURPOSE: As most thyroid cancer patients survive for more than ten years, it has become increasingly important to understand whether the different surgery types have any effect on the quality of life (QoL) of patients. PATIENTS AND METHODS: Using observational data from head and neck surgery at the Sichuan Cancer Hospital in China, three scoring methods - sum scoring, domain-based scoring and IRT-based scoring, were employed to measure the QoL in differentiated thyroid cancer (DTC) patients and a propensity score matched analysis performed to explore the impact of surgery type on QoL as measured by the Treatment of Cancer Quality of Life core Questionnaire version 3.0 (EORTC QLQ-C30) and a disease-specific health-related quality of life questionnaire (THYCA-QoL). RESULTS: No statistically significant patient QoL differences were found between the two surgery types regardless of which questionnaire was used and which scoring method was used (, using the EORTC QLQ-C30 and the sum scoring; , using the EORTC QLQ-C30 and the domain-based scoring; and , using the EORTC QLQ-C30 and the IRT-based scoring; , using the THYCA-QoL and the sum scoring; , using the THYCA-QoL and the domain-based scoring; and , using the THYCA-QoL and the IRT-based scoring). CONCLUSION: This study confirmed that the surgery type (hemithyroidectomy or total thyroidectomy) for DTC patients did not appear to influence their general QoL.
PURPOSE: As most thyroid cancer patients survive for more than ten years, it has become increasingly important to understand whether the different surgery types have any effect on the quality of life (QoL) of patients. PATIENTS AND METHODS: Using observational data from head and neck surgery at the Sichuan Cancer Hospital in China, three scoring methods - sum scoring, domain-based scoring and IRT-based scoring, were employed to measure the QoL in differentiated thyroid cancer (DTC) patients and a propensity score matched analysis performed to explore the impact of surgery type on QoL as measured by the Treatment of Cancer Quality of Life core Questionnaire version 3.0 (EORTC QLQ-C30) and a disease-specific health-related quality of life questionnaire (THYCA-QoL). RESULTS: No statistically significant patient QoL differences were found between the two surgery types regardless of which questionnaire was used and which scoring method was used (, using the EORTC QLQ-C30 and the sum scoring; , using the EORTC QLQ-C30 and the domain-based scoring; and , using the EORTC QLQ-C30 and the IRT-based scoring; , using the THYCA-QoL and the sum scoring; , using the THYCA-QoL and the domain-based scoring; and , using the THYCA-QoL and the IRT-based scoring). CONCLUSION: This study confirmed that the surgery type (hemithyroidectomy or total thyroidectomy) for DTC patients did not appear to influence their general QoL.
Authors: Fabio Efficace; Francesco Cottone; Kathrin Sommer; Jacobien Kieffer; Neil Aaronson; Peter Fayers; Mogens Groenvold; Giovanni Caocci; Francesco Lo Coco; Gianluca Gaidano; Pasquale Niscola; Michele Baccarani; Gianantonio Rosti; Adriano Venditti; Emanuele Angelucci; Paola Fazi; Marco Vignetti; Johannes Giesinger Journal: Value Health Date: 2019-08-07 Impact factor: 5.725
Authors: Briseis Aschebrook-Kilfoy; Benjamin James; Sapna Nagar; Sharone Kaplan; Vanessa Seng; Habibul Ahsan; Peter Angelos; Edwin L Kaplan; Marlon A Guerrero; Jennifer H Kuo; James A Lee; Elliot J Mitmaker; Jacob Moalem; Daniel T Ruan; Wen T Shen; Raymon H Grogan Journal: Thyroid Date: 2015-12-01 Impact factor: 6.568
Authors: Hendrieke C Hoftijzer; Karen A Heemstra; Eleonora P M Corssmit; Agatha A van der Klaauw; Johannes A Romijn; Johannes W A Smit Journal: J Clin Endocrinol Metab Date: 2007-10-23 Impact factor: 5.958
Authors: N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes Journal: J Natl Cancer Inst Date: 1993-03-03 Impact factor: 13.506
Authors: Johannes M Giesinger; Jacobien M Kieffer; Peter M Fayers; Mogens Groenvold; Morten Aa Petersen; Neil W Scott; Mirjam A G Sprangers; Galina Velikova; Neil K Aaronson Journal: J Clin Epidemiol Date: 2015-09-28 Impact factor: 6.437